|
|
| Optimizing Antibody Polishing with Mixed-Mode Chromatography | Efficient mAb polishing requires balancing impurity clearance with product recovery. See how a DoE-guided approach optimized a weak anion exchange hydrophobic interaction chromatography (AEX-HIC) mixed-mode resin for aggregate removal in flow-through mode, reducing high molecular weight species from 7.3% to 0.7% while achieving 85% mAb monomer recovery. Learn how this experimental approach can help scientists and engineers define operating conditions and evaluate polishing performance using measurable process outcomes. |
|
|
FOCUS ON DOWNSTREAM MANUFACTURING |
|
|
|
By BioPhorum | Vapor phase hydrogen peroxide has been used for decades as a surface decontaminant in pharma/biotech, but there has been little guidance on how to establish the parameters. Here's an industry consensus from BioPhorum. | |
|
|
| Rapid Process Development For Cell Line Optimization Using Protein A | Application Note | By Jess Kettner, Jeffrey Cassel, and William Barrett, Ph.D., W.L. Gore & Associates | Rapidly purify 24 monoclonal antibody samples in under eight hours with a membrane-based affinity capture that streamlines cell line optimization and accelerates early-stage bioprocess development. |
|
|
|
| Denaturing SEC-MS Analysis Of High Molecular Weight Impurities | Application Note | By Stephan Koza, Philip Wuthrich, Stephen Shiner, et al., Waters Corporation | Look at how denaturing SEC‑MS uncovers low‑level oligomers and truncated variants in GLP‑1 peptides, offering clarity on impurity profiles and supporting confident assessment of molecular integrity. |
|
|
| Reducing Costs And Improving Efficiency | E-Book | Ecolab, Purolite™ Resins | Transform your downstream workflow with modernize bioprocessing by optimizing bed height and resin selection. Improve productivity and HCP clearance while reducing costs. |
|
|
| GMP Reagent Enables Improvement In MSC-EV Processing Recovery | Poster | By Ramon Castellanos-Sanchez, Ph.D, Stephen Lenzini, Ph.D, Jae Jung, et al., RoosterBio | Filter fouling during EV purification can eliminate over 95% of your starting material. See how a novel GMP-compatible reagent changes the recovery equation entirely. |
|
|
|
DOWNSTREAM MANUFACTURING SOLUTIONS |
|
|
|
|
|
|
|
|
|
| Reducing Fill Risk In Drug Product Manufacture | Podcast | WuXi Biologics | How robotic, gloveless fill‑finish cuts aseptic risk, enables flexible containers, and scales manufacturing—connecting advanced automation to patient safety and operational efficiency. |
|
|
| What Sterile Injectable Sponsors Need To Know | Q&A | An Executive Q&A with Ryan Downey, August Bioservices | Late-stage sterile injectable manufacturing demands balancing compliance, capacity, and complexity. Early investment in validated systems streamlines scale-up and launch. |
|
|
| Inside Modern Fill-Finish Technology For Biologics | Article | By Hailey Dieterle, Grand River Aseptic Manufacturing | Emerging fill-finish technologies improve sterility, quality control, and flexibility while enabling prefilled systems and biologics scale-up. |
|
|
|
|
|
| Connect With Bioprocess Online: |
|
|
|